Skip to main content

Table 3 Cost outcomes

From: Comparative evaluation of isavuconazonium sulfate, voriconazole, and posaconazole for the management of invasive fungal infections in an academic medical center

Characteristic Total (n = 100) Isavuconazole (n = 33) Voriconazole (n = 34) Posaconazole (n = 33) P-value
Total drug cost, $ 3912 [2499; 6635] 3570 [2476; 6458] 3891 [3013; 4904] 4798 [2546; 8011] 0.360
Total drug cost per day, $ 478 [369; 625] 500 [396; 625] 369 [302; 474] 624 [485; 787] < 0.001
Therapeutic drug monitoring, n (%) 22 (22) 0 (0) 14 (41.2) 8 (24.2) < 0.001
Total cost, $ 4032 [2499; 6703] 3571 [2476; 6458] 4011 [3013; 4904] 4798 [2546; 8131] 0.360
  1. Medians with IQR